Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v5-FR
Language French French
Date Updated 2020-04-17 2020-04-17
Drug Identification Number 02331624 02331624
Brand name AZARGA AZARGA
Common or Proper name AZARGA OPH SUSP 5ML AZARGA OPH SUSP 5ML
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients TIMOLOL BRINZOLAMIDE TIMOLOL BRINZOLAMIDE
Strength(s) 0.5% 1.0% 0.5% 1.0%
Dosage form(s) SUSPENSION SUSPENSION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5ML 5ML
ATC code S01ED S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2020-02-17 2020-02-17
Actual start date
Estimated end date 2020-04-02 2020-04-02
Actual end date 2020-04-03 2020-04-03
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Limited quantity available for shipping Limited quantity available for shipping
Health Canada comments